Recent Finacing
Recent Raise
32 Biosciences develops an AI/ML and mass spectrometry diagnostic platform that quantitatively assesses gut microbiome functional health and advances a non‑antibiotic antimicrobial therapeutic targeting virulence and mucosal protection.
